20083 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Excipients; Inactive ingredients; Organic compounds, e.g. phospholipids, fats Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Method of treating major depressive disorder
#602Crystallized oxalate decarboxylase and methods of use
#603SOLID FOSMETPANTOTENATE FORMULATIONS
#604Injectable long-acting naltrexone microparticle compositions
#605MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME
#606Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
#607Methods for treatment of pulmonary hypertension
#608Formulations and methods for lyophilization and lyophilates provided thereby
#609HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS
#610ANTIGENIC THERMOSTABLE POLIO VACCINES & RELATED METHODS
#611Novel Formulation of Meloxicam
#612COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL
#613Methods for treating diseases associated with abnormal ACVR1 expression and ACVR1 inhibitors for use in the same
#614NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF
#615SOLID PARTICLES
#616FORMULATIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID
#617IMMEDIATE-RELEASE TABLETS CONTAINING A DRUG AND PROCESSES FOR FORMING THE TABLETS
#618Mannitol granules for direct compression
#619BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
#620Immediate release formulations of cannabinoids
#621A PHARMACEUTICAL COMPOSITION COMPRISING RACECADOTRL AND PROCESS FOR PREPARING THE SAME
#622Methods for treating lung disorders
#623Suspension formulation comprising an insulinotropic peptide
#624EXTENDED RELEASE FORMULATIONS OF CANNABINOIDS
#625Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
#626MULTIPARTICULATE FORMULATIONS OF CANNABINOIDS
#627Granulated composite, rapid release tablet and method for producing same
#628Starch-free soft chew for veterinary applications
#629Crystallized oxalate decarboxylase and methods of use
#630COMPOSITIONS AND METHODS OF MANUFACTURING PROTEIN MICROPARTICLES
#631Efficient aqueous encapsulation and controlled release of bioactive agents
#632Cannabis compositions and methods of making the same
#633STABLE MULTIPARTICULATE PHARMACEUTICAL COMPOSITION OF ROSUVASTATIN
#634ORAL PHARMACEUTICAL DOSAGE FORMS
#635FORMULATION
#636Dry powder Vancomycin compositions and associated methods
#637Biphenyl compounds useful as muscarinic receptor antagonists
#638Cannabinoid compositions and uses
#639Heat-stable dry powder pharmaceutical compositions and methods
#640ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
#641Virus
#642Eutectic formulations of cyclobenzaprine hydrochloride
#643OSMOTIC DRUG DELIVERY SYSTEM
#644Medical treatment comprising enteral administration of edaravone
#645FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE
#646COMPOSITION AND METHOD FOR INHALATION
#647Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof
#648Norovirus deactivator and method for producing same, method for deactivating norovirus, method for producing lysozyme component for norovirus deactivation use, prophylactic or therapeutic agent for norovirus infection, and external preparation for skin for norovirus deactivation purposes
#649Methods for treating lung disorders
#65017-hydroxyprogesterone ester-containing oral compositions and related methods
#651Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#652Preparation of respirable zafirlukast particles
#653Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#654Pharmaceutical formulations of neflamapimod
#655Pharmaceutical composition and administrations thereof
#656POWDER FORMULATION
#657Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
#658Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-A]pyridine-3-carbonitrile
#659ORAL MODIFIED RELEASE FORMULATIONS
#660Treatment using dantrolene
#661Crystalline freebase forms of a biphenyl compound
#662Compositions and methods for treatment
#663INHALABLE POWDER COMPOSITION COMPRISING IL-13 ANTIBODY
#664Composition for treatment of infertility in a female subject
#665COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS
#666Compounds for cancer chemotherapeutic sensitization
#667Compositions comprising PGI2-receptor agonists and processes for the preparation thereof
#668Intranasal delivery of olanzapine by precision olfactory device
#669Peptide YY pharmaceutical formulations, compositions, and methods
#670METHOD FOR PRODUCING SOLID DISPERSION COMPRISING RAPAMYCIN DERIVATIVE
#671Manufacture of Degarelix
#672Compositions comprising proanthocyanidins and oenothein B
#673Crystalline microspheres and the process of manufacturing the same
#674Pharmaceutical suspension dosage form of benzimidazole compounds and process of preparation thereof
#675PIRFENIDONE-CONTAINING TABLET AND CAPSULE FORMULATION
#676Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
#677High-pH solid-state epinephrine formulation
#678PHARMACEUTICAL COMPOSITIONS CONFIGURED TO DETER DOSAGE FORM SPLITTING
#679Solid composition for quick ingestion with facilitated swallowing, in the form of solid, non-agglomerated particles, comprising two different types of particles
#680PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#681Microparticles for encapsulating probiotics, obtaining said microparticles and uses thereof
#682COMPOSITION CONTAINING SQUALENE FOR IMPROVING MUSCLE FUNCTION AND PREVENTING MUSCLE DAMAGE
#683COMPOSITIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS
#684Microparticles comprising a sulphur-containing compound
#685METABOLITES FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE
#686Micronized Opioid Compositions, Formulations and Dosage Forms and Methods of Making Same
#687Solid beverage for conditioning allergic constitution and method for producing the same
#688Pharmaceutical compositions
#689Process for mesalazine solid formulations
#690Compositions, methods and uses for thermally stable multi-targeted antigens
#691NICOTINE PARTICLES AND COMPOSITIONS
#692Nanocrystal Microparticles of Poorly Soluble Drugs and Methods of Production and Use Thereof
#693POLYMER-BASED SUSTAINED RELEASE DEVICE
#694Powder formulation
#695Powder for regulating intestinal flora and protecting gastric mucosa, preparation method and use thereof
#696COMPOSITIONS COMPRISING PROTON PUMP INHIBITORS FOR ORAL ADMINISTRATION
#697Pharmaceutical dosage forms comprising valganciclovir hydrochloride
#698Pharmaceutical compositions
#699Granule Formulation for Oral Administration
#700Solid oral formulation of fenretinide
#701Nicotine particles
#702COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS
#703Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances with Reduced Ostwald Ripening
#704Solid composition comprising iron for use in iron deficient conditions
#705Formulations and methods for lyophilization and lyophilates provided thereby
#706Composition comprising fine particle and process thereof
#707Dry powder formulations for inhalation
#708Biguanide compositions and methods of treating metabolic disorders
#709PHARMACEUTICAL COMPOSITION OF ENTECAVIR AND PROCESS OF MANUFACTURING
#710Controlled release delivery device comprising an organosol coat
#711Method of production of inhalable composite particles using a three-fluid nozzle
#712Thrombin microcapsules, preparation and uses thereof
#713Radiation - Sterilized Biodegradable Drug Delivery Compositions
#714Enhanced thermal stability for adenoviral vectors through spray drying
#715Continuous complexation of active pharmaceutical ingredients
#716Granular Pharmaceutical Composition
#717Stabilized formulations of CNS compounds
#718Method for preparing pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compound
#719TIZANIDINE FORMULATIONS
#720Powder for oral suspension containing lamotrigine
#721Reduction of stinging sensation on skin
#722Pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compound
#723Method for preparing pharmaceutical composition comprising quinoline derivative or salt thereof
#724Biphenyl compounds useful as muscarinic receptor antagonists
#725EXTENDED RELEASE LIQUID COMPOSITIONS OF GUAIFENESIN
#726A UNIQUE HIGH-SHEAR GRANULATION PROCESS FOR IMPROVED BIOAVAILABILITY OF RIVAROXABAN
#727POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS
#728PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#729Method, composition and package for bowel cleansing
#730Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
#731Sumatriptan promethazine pharmaceutical compositions
#732Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#733Pharmaceutical compositions and dosage forms
#734PHARMACEUTICAL COMPOSITION COMPRISING RAPAMYCIN OR DERIVATIVE THEREOF
#735Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#736Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#737PROCESS FOR OBTAINING A BIOPOLIMERIC HEMOSTATIC POWDER AND THE PRODUCT
#738Apixaban solid composition and preparation method thereof
#739Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#740Embolic microspheres
#741Premixture and pharmaceutical composition for the oral administration of memantine as a permanent suspension or one prepared prior to administering to the patient and optionally by enteral feeding tube and corresponding procedures
#742Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient
#743PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THE SAME
#744SOLID DOSAGE FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)PYRIMIDIN-4-YL)PHENYL)PROPANOATE
#745PULSATILE RELEASE PHARMACEUTICAL COMPOSITION COMPRISING NAFTAZONE OR ONE OF ITS SALTS
#746Sodium diacetate crystal and solid dialysis preparation comprising said crystal
#747Pazopanib formulation
#748Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#749Delayed sustained release pharmaceutical compositions
#750Methods for treating lung disorders
#751FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
#752Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#753AMORPHOUS DISPERSION GRANULES AND ORAL DOSAGE FORMS
#754Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide
#755Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
#756Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
#757Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy]-N-(methylsulfonyl)acetamide
#758KDM1A inhibitors for the treatment of disease
#759Oral amphetamine composition
#760Pharmaceutical composition containing clomipramine and preparation method therefor
#761TERNARY MIXTURE FORMULATIONS
#762An Oral Preparation for the Treatment of Cardiovascular Disease and Its Preparation Method
#763METHOD OF MAKING DIALKYL SULFOSUCCINATE COMPOSITIONS
#764PHARMACEUTICAL COMPOSITION OR FUNCTIONAL HEALTH FOOD FOR PREVENTING AND TREATING METABOLIC DISEASES, CONTAINING WATER EXTRACT OF PLEUROTUS ERYNGII VAR. FERULAE (PF.) AS ACTIVE INGREDIENT
#765Rapidly Dispersible Dosage Form with High Drug Content
#76617-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODS
#767Formulation for targeting cancer in humans and canines using chlorotoxin
#768Composite granulated product including sugar or sugar alcohol, swelling binder, disintegrating agent and highly absorbent excipient, and method for manufacturing composite granulated product
#769SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS
#770Oral particulate composition
#771ORAL AMPHETAMINE COMPOSITION
#772Devices, formulations, and methods for delivery of multiple beneficial agents
#773Novel formulation of metaxalone
#774Reduction of flake-like aggregation in nanoparticulate active agent compositions
#775Nanosuspension formulation
#776Microbiota restoration therapy (MRT) compositions and methods of manufacture
#777Pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof
#778Solid soluble ferric pyrophosphate formulations, kits, and methods using the same
#779METHOD FOR TREATING INTESTINAL FIBROSIS
#780STABLE PHARMACEUTICAL COMPOSITION OF ALOGLIPTIN AND METFORMIN FIXED DOSE COMBINATION
#781Heat stable liquid rotavirus vaccine
#782Gastro-resistant formulation containing posaconazole
#783Modified release compositions comprising tacrolimus
#784Drug for the effective control of acute and or chronic pain and a method for its administration
#785Heat-stable dry powder pharmaceutical compositions and methods
#786NEW ALFENTANIL COMPOSITION FOR THE TREATMENT OF ACUTE PAIN
#787Oral pharmaceutical dosage forms
#788Solid dispersions comprising tacrolimus
#789Disintegrating particle composition including microfibrous cellulose
#790Formulations of guanylate cyclase C agonists and methods of use
#791METHODS AND COMPOSITIONS FOR STIMULATING BENEFICIAL BACTERIA IN THE GASTROINTESTINAL TRACT
#792Composition for hair loss prevention or hair growth stimulation comprising extract
#793Crystalline freebase forms of a biphenyl compound
#794MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#795Bendamustine Solid Dispersions And Continuous Infusion
#796Manufacture of pharmaceutical compositions
#797PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#798Orodispersible dosage unit containing an estetrol component
#799Abuse-proof solid pharmaceutical composition
#800NOVEL PHARMACEUTICAL DOSAGE FORMS COMPRISING VALGANCICLOVIR HYDROCHLORIDE
#801Alogliptin formulation
#802Treatment using dantrolene
#803Orally disintegrating solid dosage unit containing an estetrol component
#804Stimulant abuse-deterrent compositions
#805ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF
#806COMPOSITIONS AND METHODS OF USING (R)-PRAMIPEXOLE
#807ANTIMICROBIAL ALGINATE-BASED MICROPARTICLES AND RELATED MATERIALS AND METHODS
#808Dry powder formulation of azole derivative for inhalation
#809Granulate for the formulation of orodispersible tablets
#810Crystallized oxalate decarboxylase and methods of use
#811Composition for wound treatment containing extract of or fraction thereof and method for treating wound of subject
#812Bendamustine pharmaceutical compositions
#813Process for manufacturing dry powder blends
#814COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIA
#815Solid pharmaceutical dosage form suitable for use as drinking water medication
#816Pulmonary Delivery for Levodopa
#817Method of making particles for use in a pharmaceutical composition
#818Novel Formulation of Meloxicam
#819Monensin water dispersible granules by wet granulation
#820Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
#821Curcumin solid lipid particles and methods for their preparation and use
#822Pharmaceutical compositions
#823Suspension containing nano-cocrystal and manufacturing method
#824Compositions and methods for transplantation of colon microbiota
#825Pharmaceutical formulation of racecadotril
#826Process for forming active domains dispersed in a matrix
#827Novel formulation of metaxalone
#828FORMULATIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID
#829PHARMACEUTICAL COMPOSITION
#830COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT
#831(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
#832MODIFIED RELEASE COMPOSITIONS OF EPALRESTAT OR A DERIVATIVE THEREOF AND METHODS FOR USING THE SAME
#833NOVEL SPRAY NOZZLE AND PROCESS FOR MAKING NANOPARTICLES
#834Method of manufacturing an osmotic delivery device
#835BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
#836NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF
#837Microparticles
#838NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF
#839Controlled release of active substances
#840Disintegrative particle composition including pulverized lactose or granulated lactose
#841PROBIOTIC THERAPEUTIC APPLICATIONS
#842Pharmaceutical composition comprising dabigatran etexilate, and preparation method, solid preparation and use thereof
#843Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
#844Compositions and Methods for Transplantation of Colon Microbiota
#845STABLE POWDER FORMULATION CONTAINING AN ANTICHOLINGERIC AGENT
#846Pharmaceutical composition containing budesonide and formoterol
#847Manufacture of Degarelix
#848Compositions and Methods for Transplantation of Colon Microbiota
#849Composition based on COQ10
#850DICLOFENAC FORMULATIONS AND METHODS OF USE
#851METHODS OF MANUFACTURING VISCOUS LIQUID PHARMACEUTICAL FORMULATIONS
#852Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture
#853Amorphous form of lomitapide mesylate
#854METHODS AND COMPOSITIONS FOR INHALATION DELIVERY OF CONJUGATED OLIGONUCLEOTIDE
#855Method of activating lactic acid bacteria
#856AN INHALABLE RAPAMYCIN FORMULATION FOR THE TREATMENT OF PULMONARY HYPERTENSION
#857Solid pharmaceutical preparation containing levothyroxine
#858MANUFACTURE OF A PHARMACEUTICAL PRODUCT
#859Process for preparing a directly compressible erythritol and uses thereof
#860Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID)
#861Eutectic formulations of cyclobenzaprine hydrochloride
#862Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#863Antidiabetic Solid Pharmaceutical Compositions
#864Pharmaceutical composition of polyethylene glycol-modified camptothecin derivative and preparation method thereof
#865NOVEL PHARMACEUTICAL DOSAGE FORMS COMPRISING VALGANCICLOVIR HYDROCHLORIDE
#866Injectable neurosteroid formulations containing nanoparticles
#867Spray-Freeze Drying of Polyelectrolyte Nanoparticles Containing the Protein Drug
#868Compositions and methods for transplantation of colon microbiota
#869Oral pharmaceutical dosage forms
#870Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
#871Compositions and methods for transplantation of colon microbiota
#872Formulation of meloxicam
#873Formulation and method for producing same
#874Lactic acid bacterium
#875Water-soluble granular material for producing a drinking soltuion
#876Method and formulation for inhalation
#877Direct compression excipient based on lactose, cellulose and starch
#878Formulations of guanylate cyclase C agonists and methods of use
#879Formulations of guanylate cyclase C agonists and methods of use
#880Compositions comprising extract and preparation method and uses thereof
#881Combination formulation of two antiviral compounds
#882RADIATION-STERILIZED BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#883Composition and method for treating chagas disease
#884Polymer protein microparticles
#885Polypeptides, antibody variable domains and antagonists
#886Thermostable spray dried rotavirus vaccine formulation and process thereof
#887Compositions comprising extract and preparation method and uses thereof
#888Process for preparing a medicament
#889Rapidly dispersible dosage form of oxcarbazepine
#890SOLID DOSAGE FORM COMPRISING PROTON PUMP INHIBITOR AND SUSPENSION MADE THEREOF
#891PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS
#892Thrombin microcapsules, preparation and uses thereof
#893BIOCOMPATIBLE COLLOIDAL SOLUTION OF GOLD NANOPARTICLES IN NON-AQUEOUS POLAR SOLVENT AND METHOD OF OBTAINING THEREOF
#894Microneedle-based transdermal delivery system and method of making same
#895Gelatin/pectin particles
#896Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof
#897Antigen-loaded chitosan nanoparticles for immunotherapy
#898FORMULATION FOR ORAL ADMINISTRATION CONTAINING MESALAZINE
#899Treatment using dantrolene
#900Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic